Appendix E - National Coverage Determinations Manual / Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndrome (MDS) 90.3.1

Why This Topic Matters

Coverage determinations can affect whether a transplant-related service is payable under Medicare and whether additional coverage requirements apply. Understanding the policy helps billing and compliance teams identify when the service is addressed by national policy versus left to contractor discretion.

Article Sections

1. A. General

   Provides a general overview of allogeneic stem cell transplantation and references the code sets associated with the procedure. It also notes coverage considerations related to donor expenses.

2. B. Covered Conditions

   Lists the conditions and effective dates for which the service is addressed as covered under the policy. This section presents the broad categories of diagnoses referenced by the determination.

3. C. Non-Covered Conditions

   Identifies conditions and effective dates for which the service is not covered under the policy, including the special coverage framework for myelodysplastic syndrome. It also references Medicare-approved clinical study requirements and related manual guidance.